{
  "pmcid": "5706650",
  "sha256": "346ee2a136b81a3298cc7a125c1a8637d1eea2f06472b0b1a7b202fd5f105af4",
  "timestamp_utc": "2025-11-09T23:58:48.553294+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.967731092436974,
    "reading_ease": 20.5899159663866,
    "word_count": 245
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Atrioventricular Conduction Prolongation in Cardiac Pacing"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Conducted as a single-center, randomized controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "cardiac surgical patients at risk of left ventricular failure post-cardiopulmonary bypass"
      },
      "Intervention": {
        "score": 1,
        "evidence": "The intervention involved temporary BiVP optimization, with no specific control group."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to estimate atrial conduction using AVCP and evaluate its role in optimizing paced atrioventricular delay (pAVD) during biventricular pacing (BiVP)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "Primary outcomes were optimum cardiac output (OptCO) and mean arterial pressure (OptMAP), assessed immediately post-bypass."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Randomization and allocation concealment methods were not detailed."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding of outcome assessors, patients, and clinicians was not specified."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Seven patients were randomized, with three assigned to the short-AVCP group (<64 ms) and four to the long-AVCP group (>64 ms)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "OptCO and OptMAP were significantly lower in the short-AVCP group (p = 0.015 and p = 0.029)."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 10,
    "max_score": 25
  }
}